[1]
“In Silico Study of Secondary Metabolite Compound from Noni fruit (Morinda citrifolia) as Potential Drug Candidates for Type 2 Diabetes Mellitus Targeting PPAR-γ”, ijcs, vol. 14, no. 1, pp. 38–46, Apr. 2025, doi: 10.15294/ijcs.v14i1.8966.